Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Welazid N (Lamivudine, Stavudine & Nevirapine Tablets 650 mg)
Welazid N is a combination antiretroviral medication used in the treatment of HIV-1 infection. By combining Lamivudine, Stavudine, and Nevirapine, it provides an effective, comprehensive approach to suppressing viral replication and boosting the immune system.
Uses of Welazid N
Helps manage HIV-1 infection effectively.
Reduces the viral load and improves CD4 cell count.
Slows down disease progression and delays complications.
Benefits of Welazid N
Triple-action formula for enhanced effectiveness.
Reduces the risk of opportunistic infections.
Improves overall immune function and health.
Convenient fixed-dose combination for better adherence.
Mechanism of Action of Welazid N
Lamivudine & Stavudine inhibit the viral reverse transcriptase enzyme, preventing replication.
Nevirapine binds to the reverse transcriptase enzyme, stopping the virus from multiplying.
Reduces viral load, preventing immune system damage.
Welazid N – Comprehensive HIV Treatment for a Stronger Immune System!